...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Design, synthesis and biological evaluation of novel 5-fluoro-1H-benzimidazole-4-carboxamide derivatives as potent PARP-1 inhibitors
【24h】

Design, synthesis and biological evaluation of novel 5-fluoro-1H-benzimidazole-4-carboxamide derivatives as potent PARP-1 inhibitors

机译:新型5-氟-1H-苯并咪唑-4-羧酰胺衍生物作为强效PARP-1抑制剂的设计,合成和生物学评价

获取原文
获取原文并翻译 | 示例
           

摘要

A series of novel 5-fluorine-benzimidazole-4-carboxamide analogs were designed and synthesized. All target compounds were evaluated for their PARP-1 inhibitory activity. Compounds possessed high intrinsic PARP-1 inhibitory potency have been evaluated in vitro cellular assays to measure the potentiation effect of cytotoxic agents against cancer cell line. These efforts led to the identification of compound 10f, which displayed strong inhibition against the PARP-1 enzyme with an IC50 of 43.7 nM, excellent cell inhibitory activity in HCT116 cells (IC50 = 7.4 mu M) and potentiation of temozolomide cytotoxicity in cancer cell line A549 (PF50 = 1.6). (C) 2016 Elsevier Ltd. All rights reserved.
机译:设计并合成了一系列新颖的5-氟-苯并咪唑-4-羧酰胺类似物。评价所有目标化合物的PARP-1抑制活性。具有高固有PARP-1抑制能力的化合物已在体外细胞分析中进行了评估,以测量细胞毒剂对癌细胞系的增强作用。这些努力导致了化合物10f的鉴定,该化合物显示出对PARP-1酶的强抑制作用,IC50为43.7 nM,在HCT116细胞中具有出色的细胞抑制活性(IC50 = 7.4μM),并增强了癌细胞系中替莫唑胺的细胞毒性A549(PF50 = 1.6)。 (C)2016 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号